Cel-Sci
CVM
#9791
Rank
C$66.39 M
Marketcap
C$7.90
Share price
-1.19%
Change (1 day)
-54.15%
Change (1 year)

Cel-Sci (CVM) - Net assets

Net assets on the balance sheet as of September 2025 : C$21.72 Million

According to Cel-Sci 's latest financial reports the company has C$21.72 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cel-Sci - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-09-30$C$22.21 M27.65%
2024-09-30$C$17.4 M-3.09%
2023-09-30$C$17.95 M-59.47%
2022-09-30$C$44.31 M-38.2%
2021-09-30$C$71.7 M173.21%
2020-09-30$C$26.24 M286.1%
2019-09-30$C$6.79 M577863.61%
2018-09-30$C$0 M-100.03%
2017-09-30$-C$4.14 Million363.01%
2016-09-30$-C$0.9 Million-85.9%
2015-09-30$-C$6.35 Million-154.19%
2014-09-30$C$11.7 M69.19%
2013-09-30$C$6.91 M0.01%
2012-09-30$C$6.91 M-26.51%
2011-09-30$C$9.41 M-67.23%
2010-09-30$C$28.71 M199.53%
2009-09-30$C$9.58 M-16.79%
2008-09-30$C$11.52 M-20.83%
2007-09-30$C$14.55 M-1500.17%
2006-09-30$-C$1.04 Million-142.15%
2005-09-30$C$2.46 M-52.56%
2004-09-30$C$5.19 M215.4%
2003-09-30$C$1.64 M-1.7%
2002-09-30$C$1.67 M-73.47%
2001-09-30$C$6.31 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
C$107.91 B 496,713.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$13.09 B 60,180.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.85 B 3,818.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-C$20 Million-192.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$9.87 B 45,359.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
-C$0.53 Billion-2,530.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$0.79 B 3,550.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
C$4.85 M-77.63%๐Ÿ‡บ๐Ÿ‡ธ USA